޲Ʊ

Initiatives for Improving Access to Medicines for Non-communicable Diseases

Flexible Pricing Policy in Emerging and Developing Countries

In addition to the patient contribution through innovative new drug development and sales, ޲Ʊ has established a core strategy consisted of affordable pricing, provision of disease solutions, public-private partnerships and local partnerships, to contribute to improving access to medicines in emerging and developing countries.

Related Links